{
  "id": 240941,
  "title": "Biogen Completes Acquisition of RayThera Inc.",
  "url": "https://urgent.news/2026/08/06/biogen-completes-acquisition-of-raythera-inc",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-06T22:17:47.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/biogen-completes-acquisition-of-raythera-inc"
  },
  "original_language": "en",
  "account": null,
  "summary": "Lead program now in Phase 1 development CAMBRIDGE, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced the completion of the acquisition of RayThera Inc., a privately held biotechnology company focused on discovering and developing small-molecule therapies in immunology. The acquisition strengthens Biogen’s growing immunology portfolio, adding multiple assets that…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}